logo
Αρχική Σελίδα ΠροϊόνταΕξάρτηση δοκιμής της ELISA

Measles Virus IgM ELISA Test Kit 96T Early Acute Infection Detection

Πιστοποίηση
Κίνα Biovantion Inc. Πιστοποιήσεις
Αναθεωρήσεις πελατών
Πολύ καλός. όλα ήταν πλήρη. Ευχαριστίες

—— Χαρά prado-Φιλιππίνες Maryl

Πολύ καλή και εύκολη επικοινωνία. Τα προϊόντα ελειτούργησαν καλά και με τους θετικούς ελέγχους και με τις ομάδες δοκιμής. Θα διέταζε πάλι χωρίς δισταγμό.

—— Olof Olson, Ηνωμένες Πολιτείες

Είμαι Online Chat Now

Measles Virus IgM ELISA Test Kit 96T Early Acute Infection Detection

Measles Virus IgM ELISA Test Kit 96T Early Acute Infection Detection
Measles Virus IgM ELISA Test Kit 96T Early Acute Infection Detection

Μεγάλες Εικόνας :  Measles Virus IgM ELISA Test Kit 96T Early Acute Infection Detection

Λεπτομέρειες:
Τόπος καταγωγής: Κίνα
Μάρκα: Biovantion
Πιστοποίηση: ISO13485
Αριθμό μοντέλου: BVTE159
Πληρωμής & Αποστολής Όροι:
Ποσότητα παραγγελίας min: 10
Τιμή: Διαπραγματεύσιμα
Συσκευασία λεπτομέρειες: Χαρτοκιβώτιο
Χρόνος παράδοσης: 7-15 ημέρες
Όροι πληρωμής: TT 100% ΠΛΗΡΩΜΗ
Δυνατότητα προσφοράς: 100000

Measles Virus IgM ELISA Test Kit 96T Early Acute Infection Detection

περιγραφή
Δείγμα: Ορός 50μl Τύπος δείγματος: Ορός, πλάσμα,
Εφαρμογές: Ιατρική Διάγνωση Κατασκευαστής: Biovantion
Τύπος δοκιμής: Κιτ δοκιμής IgM ELISA για τον ιό της ιλαράς χώρα προέλευσης: Κίνα
Χρόνος δοκιμασίας: 90 λεπτά Θερμοκρασία αποθήκευσης: 2-8°C

Measles Virus IgM Elisa test kit

Product Overview

The Measles Virus IgM ELISA Test Kit is an in vitro diagnostic enzyme-linked immunosorbent assay designed for the qualitative detection of IgM antibodies against Measles virus in human serum or plasma samples. This kit is specifically optimized for the early diagnosis of acute measles infection, enabling timely clinical intervention and public health surveillance.

Key Features

  • Early Detection: Detects IgM antibodies as early as 3-7 days after onset of symptoms
  • High Sensitivity & Specificity: Recombinant antigen-based assay with minimal cross-reactivity
  • 96 Tests per Kit: High-throughput format ideal for clinical laboratories and outbreak screening
  • Rapid Turnaround: Total assay time of approximately 2.5 hours
  • CE Marked: Compliant with European In Vitro Diagnostic Directive (IVDD)
  • Room Temperature Incubation: Compatible with standard ELISA laboratory setups
  • Long Shelf Life: 12 months stability at 2-8°CMeasles Virus IgM ELISA Test Kit 96T Early Acute Infection Detection 0

Principle of the Test

This ELISA kit utilizes a capture antibody method (μ-chain capture) for the detection of Measles virus-specific IgM antibodies. Microtiter wells are pre-coated with anti-human IgM (μ-chain) monoclonal antibodies. Patient samples are added, and any IgM antibodies present are captured by the immobilized anti-μ antibodies. After washing to remove non-specific immunoglobulins (including IgG), horseradish peroxidase (HRP)-conjugated recombinant Measles virus antigens are added, which bind specifically to the captured Measles virus IgM antibodies. Following a second wash, TMB substrate solution is added, producing a blue color reaction proportional to the concentration of Measles virus IgM antibodies. The reaction is stopped with sulfuric acid, turning the solution yellow, and absorbance is measured at 450 nm.

Specifications

  • Sample Type: Human serum or plasma (EDTA, heparin)
  • Sample Volume: 100 μL per well (1:100 dilution)
  • Incubation Temperature: 37°C
  • Incubation Time: 60 min (Sample) + 30 min (Conjugate) + 15 min (Substrate)
  • Detection Wavelength: 450 nm (reference: 620-630 nm)
  • Storage Condition: 2-8°C, protect from light
  • Shelf Life: 12 months from date of manufacture
  • Format: 96-well break-apart strip microplate

Performance Characteristics

  • Clinical Sensitivity: 98.5% (in acute-phase samples collected 3-14 days post-onset)
  • Clinical Specificity: 99.2%
  • Overall Agreement: 98.9% compared to reference method
  • Intra-assay CV: ≤ 8.0%
  • Inter-assay CV: ≤ 10.0%
  • Cross-reactivity: No significant cross-reactivity with Rubella, Mumps, VZV, HSV, CMV, EBV, Parvovirus B19, or Enterovirus
  • Rheumatoid Factor Interference: Built-in RF adsorbent minimizes false positives from rheumatoid factor

Clinical Significance

Measles virus IgM antibodies are typically detectable within 3-7 days after the onset of rash and symptoms, peaking at 2-3 weeks, and gradually declining over 2-3 months. A positive IgM result is indicative of:
  • Primary acute measles infection (in non-vaccinated individuals)
  • Recent vaccine-induced seroconversion (in recently vaccinated individuals)
  • Reinfection or booster response (in previously immune individuals, typically with lower IgM titers)

Intended Use

  • Early diagnosis of acute measles virus infection in symptomatic patients
  • Outbreak investigation and public health surveillance
  • Confirmatory testing for suspected measles cases
  • Differentiation between acute infection (IgM positive) and past immunity (IgG positive only)
  • Serological monitoring in vaccination programs

Sample Collection and Storage

  • Collect blood samples by standard venipuncture
  • Serum samples should be separated from clotted blood within 2 hours of collection
  • Plasma samples should be separated promptly and stored appropriately
  • Samples may be stored at 2-8°C for up to 7 days
  • For long-term storage, aliquot and freeze at -20°C or below
  • Avoid repeated freeze-thaw cycles (maximum 3 cycles)
  • Do not use hemolyzed, lipemic, or icteric samples

Storage and Handling

  • Store all kit components at 2-8°C upon receipt
  • Do not use reagents beyond the expiration date printed on the label
  • Allow all reagents to reach room temperature (18-25°C) before use
  • Mix reagents gently by swirling; avoid foaming
  • Return unused reagents to 2-8°C immediately after use
  • Protect TMB substrate from direct sunlight and metal contamination
  • Wash buffer concentrate may form crystals at low temperature; warm to room temperature and mix thoroughly before dilution

Quality Control

Each kit includes positive and negative controls as well as cut-off calibrators. It is recommended to run controls with each assay batch. The assay is considered valid only if:
  • Negative control OD value < 0.100
  • Positive control OD value ≥ 0.800
  • Cut-off calibrator OD value falls within the specified range

For in vitro diagnostic use only. For professional use by trained laboratory personnel. Positive results should be interpreted in conjunction with clinical findings and other laboratory tests.

Στοιχεία επικοινωνίας
Biovantion Inc.

Υπεύθυνος Επικοινωνίας: Mr. Steven

Τηλ.:: +8618600464506

Στείλετε το ερώτημά σας απευθείας σε εμάς (0 / 3000)

Άλλα προϊόντα